Letter to the Editor
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3623-3628
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3623
Table 3 Efficacy of ablation for hepatic hemangioma
Ref.
Years
Type
Treatment
Efficacy
Wen et al[29]2018Multicenter retrospective studyRFAComplete ablation was achieved in 86% of hepatic hemangiomas
Shi et al[30]2020Multicenter retrospective studyTAE vs MWAMicrowave ablation was associated with higher rates of radiological complete response (89.0% vs 37.7%) and clinical complete response (88.6% vs 69.2%), fewer minor complications (43.9% vs 66.0%), shorter duration of analgesic drug use and hospital stay
Wu et al[31]2021Multicenter retrospective studyRFAComplete ablation was achieved in 99% of hepatic hemangiomas
Kong et al[32]2022Multicenter retrospective studyMWA vs RFAMicrowave ablation was associated with shorter ablation duration, fewer hemolysis-related complications, and shorter hospital stays
Xu et al[33]2023Multicenter retrospective studyRFAComplete ablation was achieved in 95.5% of hepatic hemangiomas. Preoperative symptoms disappeared completely in 96.4% of the patients. During follow-up, 11.4% of patients with hemangioma close to completely disappear over time
Cai et al[35]2024Multicenter retrospective studyMWA vs percutaneous sclerotherapyMicrowave ablation has a lower local tumor progression rate, higher volume reduction rate, and symptom remission rate